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Background
Disruptive behavior disorders (DBD) present
high comorbidity rate mainly for opposite-defiant
disorders that are frequent among children, adoles-
cents and adults affected by with attention deficit
and hyperactivity disorder (ADHD), probably as
result of common temperamental risk factors such
as attention, distraction, impulsivity. ADHD tend to
manifest in about 50% of individuals diagnosed as
disruptive behavioral disorders(1-6).
Actually, ADHD is included in the DSM-5
chapter of neurodevelopmental disorders and
defined as a persistent pattern of inattention and/or
hyperactivity-impulsivity interfering with the nor-
mal functioning or development(1-6). 
Inattention tends to manifests as inability to
remain focused on a certain task, easy distraction,
lack of perseverance, difficulty in paying attention
to details, and organizing tasks or other daily activi-
ties. This inattention is not caused by a challenging
attitude, as can be the case in provocative opposi-
tion disorder or lack of understanding(7-15). 
Hyperactivity refers to excessive motor activi-
ty in contexts and places when inappropriate, there-
fore the subject fails to stand still, and even when it
is stopped shaking, moving hands or feet, often
leaves the place in situations where he/she must be
sitting (i.e. school, work), but hyperactivity can also
be manifested as extreme loquacity(16-20). 
Impulsivity refers to the inability to reflect,
mediate, and possibly expel behavioral responses,
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taking into account the needs defined by the con-
text. The subject does not think before acting, can-
not waiting for their turn in games or activities,
intrudes into the games and activities of others in an
intrusive way or in interrupting conversations(21-30). 
Depending on which symptom is most
expressed, the DSM-5 distinguishes the ADHD in
three categories: if there are both signs of inattention,
hyperactivity and impulsivity, we have a combined
manifestation, if there is only neglect, we talk about
manifestation with predominant inattention , and
finally the presence of hyperactivity and impulsive-
ness without any negligence outlines a manifestation
with predominant hyperactivity / impulsivity(31-50). 
On the other hand, the ICD-10 defines atten-
tion deficit and hyperactivity disorder as hyperki-
netic disorder (code F90), whose diagnosis requires
simultaneous inattention, impulsivity and hyperac-
tivity. Additionally, DSM-5 includes mild forms, if
there are few symptoms or if they cause minor
compromises in the overall functioning of the sub-
ject, serious forms if the symptoms are many or
involve marked functional impairment, and moder-
ate forms of horseback between the mild forms and
those serious. Attention deficit and hyperactivity
disorder begins in childhood, in fact the symptoms
must occur before 12 years, without specifying an
early onset due to the difficulty in establishing the
exact moment in which the symptoms appear.
Disturbance events must be present in multiple con-
texts (eg home and school, work) for more than six
months, and must interfere with the normal social
or work performance of the subject. The symptoms
of ADHD tend to have some evolution over time: in
preschool age the main manifestation is hyperactiv-
ity, while in primary school the prevalence of inat-
tention becomes impacting(51-70). 
During adolescence, signs of hyperactivity are
less common and leave more room for inner agita-
tion, restlessness, and an inner sensation of ner-
vousness. In adulthood tend to persist in inactivity
and impulsiveness, which express themselves in
making important decisions without considering the
long-term consequences, in a daunting way, of
accepting a job without information. Population
studies indicate that ADHD is present in most cul-
tures in about 5% of children and 2.5% in adults.
In the general population, ADHD is more com-
mon in males with an approximate ratio of 2: 1 in
children and 1.6: 1 in adults. Females also tend to
have males to show primarily inattention features.
Among the risk factors for the development of the
ADHD plays an important role in the presence of
familiarity, especially the presence of this disorder in
the parents of affected people is very high(49-61). 
Etiology
ADHD’s inheritance is consistent even though
no specific genes involved in genesis have been
identified this disorder. Among the relevant causes,
we can assume that the very low birth weight
(<1500g) represents a doubled or tripled risk of
developing this disorder, but on the other hand,
most children with low birth weight will not devel-
op ADHD. Exposure to toxic environmental factors
during intrauterine life such as alcohol, cigarette
smoking and childhood contact with neurotoxic
substances (such as lead) or infections (encephali-
tis) are related to subsequent development of
ADHD but It is not known whether they are related
to a causal relationship. In children with this disor-
der can also be present a history of abuse during
childhood, neglect and multiple adoptions(49-61). 
ADHD outcomes
ADHD children show reduced school out-
comes as a result of attentive difficulties, and will
also be rejected by their companions because they
are considered annoying or lazy because of their
impulsive behavior and hyperactivity. Family rela-
tionships are often characterized by discord and
negative interactions that, together with peer rejec-
tion, can lead to adolescence to develop comorbidi-
ty in a behavioral or mood disorder and in adult-
hood an antisocial personality disorder, increasing
both the risk of Suicide attempts that are likely to
develop substance abuse disorders and get into jail.
Moreover, individuals with ADHD reach a lower
level of schooling and have less personal success.
In the diagnostic test, once established that symp-
toms of hyperactivity, impulsivity, and / or discom-
fort reach a level that meets the criteria for diagnos-
ing ADHD, it is necessary to rule out that these do
not fall into other diagnostic categories, often for
example children with intellectual disabilities
Presenting hypercinetic behaviors, poor pulse con-
trol or easy distraction, but secondary, or cognitive-
like difficulties. In children with anxiety disorders
there is great difficulty in concentration and high
levels of activity, even in this case secondary to an
anxious background picture. A highly impulsive
behavior is present in intermittent explosive disor-
der which is, however, rare in infancy. An increase
in motor activity is also present in other neurode-
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velopmental disorders such as stereotyped motion
disorders and in some cases of autistic spectrum
disorder, but in these cases the motions are fixed,
stereotyped while in the ADHD the motor hyperac-
tivity is typically generalized. Inattention can also
be observed in children with specific learning dis-
abilities, but in these cases it is more due to frustra-
tion and is still limited to the school context. Many
children with mood disorders exhibit increased lev-
els of activity, poor pulse control and difficulty con-
centrating, but in this case they are also attributed
to mood disorder.
ADHD is also common as comorbid disorders,
first of all the provocative opposition disorder that
occurs in concomitant use in half the children with
ADHD. A disorder of conduct can occur in about a
quarter of children or adolescents with ADHD. The
specific learning disorder commonly occurs in con-
junction with ADHD, while less commonly the dis-
order of disruptive mood disorder, anxiety disorder,
major depressive disorder, intermittent explosive
disorder, obsessive-compulsive disorder, Tic disor-
ders, and autistic spectrum disorders. Adulthood
may occur in conjunction with the ADHD for sub-
stance abuse, even if in a minority of cases, antiso-
cial personality disorder and other personality dis-
orders. By referring to the comorbidity of disrup-
tive behavioral disorders, often provocative opposi-
tion disturbances.
The disorder of conduct, although this seems
to be more common in children with childhood
recurrence. Individuals with provocative opposition
disorder are also at greater risk of anxiety disorders
and more depressive disorder, and this seems large-
ly attributable to the presence of symptoms of
anguish / irritability. Adolescents and adults with
provocative opposition disorder also exhibit a high-
er rate of substance use disorders, although it is
unclear whether this association is independent of
comorbidity with the behavioral disorder.
How long it is common to find provocative
opposition disorder and attention deficit and hyper-
activity disorder, and this comorbid situation pre-
dicts the worst outcomes. Individuals with person-
ality features associated with antisocial personality
disorder often violate the fundamental rights of oth-
ers or the main age-appropriate social norms, and
consequently their patterns of behavior often meet
the criteria for behavioral disorders. This may also
coexist with one or more of specific learning disor-
ders, anxiety disorders (depressive or bipolar), and
substance-related disorders.
School outcomes, particularly in reading and
other verbal skills, are often inferior to those
expected by age and intelligence and can justify the
additional diagnosis of specific learning disorder or
communication disorder(71-100). 
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